Novartis (SIX: NOVN) is a Swiss multinational pharmaceutical company based in Basel, Switzerland.
The firm is one of the world's largest by annual revenue and market capitalization. As of 2022, the five therapeutic areas that Novartis focuses investment in are cardiovascular, immunology, neuroscience, solid tumors and hematology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze